HBsAg loss in chronic hepatitis B patients with an HBsAg decline plateau can be enhanced by intermittent PEG-IFN treatment

BackgroundDuring interferon (IFN) treatment patients with chronic hepatitis B (CHB), HBsAg levels often declines to a plateau. This study investigated the HBsAg loss rate in patients receiving continuous IFN treatment after reaching a plateau compared with patients who suspended IFN treatment for 3–...

ver descrição completa

Detalhes bibliográficos

Principais autores:	Weihua Cao, Si Xie, Hongxiao Hao, Wen Deng, Lu Zhang, Yao Lu, Ruyu Liu, Shiyu Wang, Xinxin Li, Ziyu Zhang, Xin Wei, Zixuan Gao, Linmei Yao, Shuojie Wang, Yuanjiao Gao, Yujie Wang, Mengjiao Xu, Leiping Hu, Yao Xie, Minghui Li
Formato:	Artigo
Idioma:	Inglês
Publicado em:	Frontiers Media S.A. 2026-05-01
coleção:	Frontiers in Cellular and Infection Microbiology
Assuntos:	antiviral therapy chronic hepatitis B HBsAg loss intermittent therapy pegylated interferon
Acesso em linha:	https://www.frontiersin.org/articles/10.3389/fcimb.2026.1778016/full
Tags:	Adicionar Tag Sem tags, seja o primeiro a adicionar uma tag!